The Pharmaceutical Journal
Vol 278 No 7442 p282
10 March 2007

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

• White paper (9)
• Commissioning
• Statins (2)
• NHS
• Community pharmacy
• Pharmacy education

Letters to the Editor

National Health Service (NHS)

Community Pharmacy Wales position clarified

From E. P. Parry, FRPharmS

Community Pharmacy Wales has a great deal of sympathy with the issues raised by George Mileusnic (PJ, 17 February, p188) and David Skinner et al (PJ, 3 March, p248). They can be assured that the CPW board is aware of the issues faced by contractors of all sizes. We have been, and still are, in robust discussion with the Welsh Assembly Government, the General Practitioners Committee Wales and social services to reach a solution to the difficulties associated with third-party requests for monitored dosage systems.

We need to clear up a misunderstanding which has arisen from the news item about CPW’s advice on seven-day prescriptions (PJ, 20 January, p67). CPW was informing colleagues that GPs had been instructed by GPC Wales, via local medical committees, to stop supplying seven-day prescriptions solely for the purpose of supported monitored-dosage tray provision. The rest of the article, which uses the words “colluding” and “fraud”, represents the views expressed by GPC Wales and LMCs, and not the views of CPW, which has provided advice to contractors in Wales.

Phil Parry
Chairman
Community Pharmacy Wales

Send your letter to The Editor

Previous Topic (Statins)
Next Topic (Community pharmacy)